RAD April 2022 Conference Abstracts and Posters
210 - Treatment Patterns and Prior Medication Usage Before Dupilumab Treatment Initiation in Patients With AD: Real-World Data From GLOBOSTAD
Silvia M. Ferrucci, M. Rossi, Daria S. Fomina, Hilde Lapeere, Wen-Hung Chung, Thrasyvoulos Tzellos, Anne-Claire Fougerousse, Jiangming Wu, Zafer E. Ozturk, Marius Ardeleanu
211 - The Disease and Family Burden of Moderate-to-Severe Atopic Dermatitis (AD) in Children Aged 12 Years: PEDISTAD Observational Study
Vania Oliveira de Carvalho, Marjolein de Bruin-Weller, Ledit R.F. Ardusso, Suzanne Pasmans, Mirna Toledo-Bahena, Rajan Gupta, Lauren Bates, Annie Zhang
212 - The Impact of Moderate-to-Severe Atopic Dermatitis in Children Aged 12 Years by Race: An Analysis of the Real-World PEDISTAD Study
Danielle Marcoux, Marie-Louise Schuttelaar, Martti Antila, Mirna Toledo-Bahena, Lacey Kruse, Rajan Gupta, Annie Zhang
213 - Dupilumab Treatment Improves Health-Related Quality of Life in Children Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis
Amy S. Paller, Eric L. Simpson, Elaine C. Siegfried, Michael J. Cork, Andreas Wollenberg, Peter D. Arkwright, Haixin Zhang, Zhixiao Wang, Ainara RodrÃguez Marco
214 - Poor Control of Atopic Dermatitis in Young Children in the United States: Results from the EPI-CARE Survey
Eric L. Simpson, Jonathan I. Silverberg, Stephan Weidinger, Lysel Brignoli, Ryan B. Thomas, Chien-Chia Chuang, Ana B. Rossi
215 - Family Impact of Moderate-to-Severe Atopic Dermatitis in Children Aged 12 years: Results From 732 Patients in the PEDIatric STudy in Atopic Dermatitis (PEDISTAD) Observational Study
Marjolein de Bruin-Weller, Marie L.A. Schuttelaar, Charles W. Lynde, Nelson Augusto Rosario Filho, Rajan Gupta, Brad Shumel, Annie Zhang
216 - Long-Term Efficacy (to 68 Weeks) of Baricitinib 4-mg in Combination with Topical Corticosteroids in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Dose Persistence Evaluation in All Continuous Baricitinib 4-mg Patients Originating from Study BREEZE-AD7
Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Thomas Werfel, Tracy E. Cardillo, Stephanie C. Colvin, Evangeline Pierce, Yun-Fei Chen, Sherry Chen, Lawrence F. Eichenfield
217 - Efficacy and Safety of Lebrikizumab in Combination with Topical Corticosteroids in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 3, Randomized, Placebo-Controlled Trial (ADhere)
Eric L. Simpson, Melinda Gooderham, Andreas Wollenberg, Stephan Weidinger, April Armstrong, Jennifer Soung, Silvia Ferrucci, Renata Gontijo Lima, Wen Xu, Michael M. Witte, Andrew Blauvelt
221 - Lebrikizumab in Combination with Topical Corticosteroids Improves Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis: Results from a Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trial (ADhere)
Seth Forman, Jan Gutermuth, Marjolein de Bruin-Weller, Angela Moore, Scott Guenthner, Eric Wolf, Evangeline Pierce, Michael M. Witte, Jinglin Zhong, Andreas Wollenberg
222 - Lebrikizumab Treatment Improves Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis: Results from Two Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trials (ADvocate1 and ADvocate2)
Peter Lio, April Armstrong, Jan Gutermuth, Audrey Nosbaum, Howard Sofen, Marta Casillas, Evangeline Pierce, Hany Elmaraghy, Sherry Chen, Jacob P. Thyssen